Hua Guo

21PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targetsTumour immunologyLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jun 06, 2026
cPLA2α inhibition potentiates anti-PD-1 immunotherapy in lung adenocarcinoma via remodeling tumor microenvironment.

|May 27, 2026
Single-Cell Landscape Change in Cervical Epithelial Cells and Microenvironment During the Transformation from CINIII to Cervical Squamous Cell Carcinoma.

|Feb 27, 2026
APOA2-mediated endothelial mesenchymal transition and cancer lipid metabolism reprogramming confers antiangiogenic drug resistance through TGF-β.

Su Zhang, Zhou Fu, Fuyi Zhu

|Jan 29, 2026
Establishment and Characterization of MCA23, a Novel Mouse Intrahepatic Cholangiocarcinoma Cell Line.

Yuchao He, Yi Luo, Liwei Chen

|Dec 02, 2025
CAV2-expressing nerves induce metabolic switch toward mitochondrial oxidative phosphorylation to promote cancer stemness.

Ze Zhang, Chunli Wang, Zhonghao Sun

|Nov 28, 2025
Low SVEP1 in intrahepatic cholangiocarcinoma mediates phenotype switching-driven metastasis by Jag2/Notch1/Hes5.

Lu Chen, Zhiqiang Han, Xiangdong Tian

Pageof 4

Frequent Collaborators

5 joint publications

Zhiyong Liu

5 joint publications

Yuchao He

4 joint publications

Zhiqiang Han

3 joint publications

Lisha Qi